Drive-thrus are not proprietary to fast food joints. IHH Malaysia, for one, is a pioneer of drive-thru COVID-19 swab tests from the onset of the pandemic. Pantai Hospital Penang has gone further by introducing drive-thru COVID-19 vaccination on 12 July.
In support of the National Covid-19 Immunisation Programme (PICK), Pantai Hospital Penang is the first private hospital in the northern region to conduct this drive-thru vaccination service.
The initiative has received positive feedback from vaccinees who praised the convenience and our staff’s efficiency in ensuring a safe and hassle-free vaccination process.
The drive-thru service is currently limited to 50 people per day and for second dose recipients only. Here’s a big THANK YOU to our staff from Pantai Hospital Penang for always putting the safety of our patients first.
Related Stories
.jpg?sfvrsn=21d67f46_1)
IHH Singapore Collaborates with Insurers to Improve Affordability of Private Hospital Care
Taking Preventive Health to New Heights at The IHH Sky Race | Merdeka 118
IHH Healthcare Malaysia highlights Care. For Good. through its role as title partner and official medical provider of The IHH Sky Race | Merdeka
Gleneagles Hospital Hong Kong Highlights Healthcare at ITB China 2026
Travel today is no longer defined by destinations alone — it is shaped by the confidence and assurance travellers carry with them.
IHH Malaysia Strengthens Care Integration Through GP-Specialist Collaboration
A referral is more than an appointment with another doctor, it is an act of trust.
Parkway MediCentre Xintiandi Launches Integrated Chinese and Western Medicine Health Management Services
Themed "Echoes of the World, Pulse of China", Parkway MediCentre Xintiandi showcased the role of Traditional Chinese Medicine (TCM) through an integrated healthcare approach.
Fortis Memorial Research Institute (FMRI) Launches India's First Centre of Excellence for Myeloma and Lymphoma
Officiated on 11 June, the FMRI Centre of Excellence, brings a highly specialised, patient‑centred and research‑driven approach to managing blood cancers.
